Zobrazeno 1 - 10
of 15
pro vyhledávání: '"David L. Niquille"'
Publikováno v:
mAbs, Vol 16, Iss 1 (2024)
ABSTRACTBiparatopic antibodies (bpAbs) bind distinct, non-overlapping epitopes on an antigen. This unique binding mode enables new mechanisms of action beyond monospecific and bispecific antibodies (bsAbs) that can make bpAbs effective therapeutics f
Externí odkaz:
https://doaj.org/article/cded80158e66447d85469dfb9b9c7945
Autor:
Andrew M. King, Daniel A. Anderson, Emerson Glassey, Thomas H. Segall-Shapiro, Zhengan Zhang, David L. Niquille, Amanda C. Embree, Katelin Pratt, Thomas L. Williams, D. Benjamin Gordon, Christopher A. Voigt
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
Peptide secondary metabolites have a diverse range of functions. Here the authors present a method to design and screen a large library of modified peptides in E. coli against a target of interest.
Externí odkaz:
https://doaj.org/article/a0b742cce7f140439048d5716ca317c3
Autor:
Aleksa Stanišić, Annika Hüsken, Philipp Stephan, David L. Niquille, Jochen Reinstein, Hajo Kries
Publikováno v:
ACS Catalysis. 11:8692-8700
Publikováno v:
Journal of the American Chemical Society. 143:2736-2740
Nonribosomal peptides (NRPs) are a therapeutically important class of secondary metabolites that are produced by modular synthetases in assembly-line fashion. We previously showed that a single Trp-to-Ser mutation in the initial Phe-loading adenylati
Autor:
Daniel A. Anderson, Amanda C. Embree, Thomas Williams, Andrew M. King, David L. Niquille, Christopher A. Voigt, Thomas H. Segall-Shapiro, Zhengan Zhang, Katelin Pratt, Emerson Glassey, D. Benjamin Gordon
Publikováno v:
Nature Communications
Nature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
Nature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
Peptide secondary metabolites are common in nature and have diverse pharmacologically-relevant functions, from antibiotics to cross-kingdom signaling. Here, we present a method to design large libraries of modified peptides in Escherichia coli and sc
Publikováno v:
Synlett. 30:2123-2130
Nonribosomal peptide synthetases produce highly modified bioactive peptides, many of which are used therapeutically. As such, they have been the target of intense protein engineering to enable biosynthetic access to peptide variants with improved dru
Autor:
Philipp Stephan, Aleksa Stanišić, David L. Niquille, Hajo Kries, Jochen Reinstein, Annika Hüsken
Engineering of nonribosomal peptide synthetases (NRPS) has faced numerous obstacles despite being an attractive path towards novel bioactive molecules. Specificity filters in the nonribosomal peptide assembly line determine engineering success, but t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0abc8db2219e35f62c61772bfc3bf22
https://doi.org/10.26434/chemrxiv.14199695
https://doi.org/10.26434/chemrxiv.14199695
Autor:
David L. Niquille, Takahiro Mori, David Fercher, Douglas A. Hansen, Hajo Kries, Donald Hilvert
Publikováno v:
Nature chemistry. 10(3)
Biosynthetic modification of nonribosomal peptide backbones represents a potentially powerful strategy to modulate the structure and properties of an important class of therapeutics. Using a high-throughput assay for catalytic activity, we show here
Publikováno v:
Angewandte Chemie (International ed. in English)
Nonribosomal peptide synthetases (NRPSs) are multifunctional enzymes that produce a wide array of bioactive peptides. Here we show that a single tryptophan-to-serine mutation in phenylalanine-specific NRPS adenylation domains enables the efficient ac
Publikováno v:
Chemistry & Biology. (5):640-648
SummaryNonribosomal peptide synthetases (NRPSs) protect microorganisms from environmental threats by producing diverse siderophores, antibiotics, and other peptide natural products. Their modular molecular structure is also attractive from the standp